Dr. Séverine Vermeire, Dr. Deanna Nguyen, and Dr. Niels Vande Casteele present Precision Medicine in IBD Clinical Research.
Dr. Vermeire presenting how a translational medicine program successfully supported the development of a new compound – a gut-selective pan-Janus kinase inhibitor.
Dr. Nguyen presenting The Application of Translational Medicine to Support an Early Drug Development Program for a Gut-Selective Compound.
Dr. Vande Casteele discusses driving innovation with method development and validation and the implementation of precision medicine in global clinical trials.
Dr. Vipul Jairath, Vice President, Medical Research and Development, Alimentiv leads a panel discussion on Precision Medicine.